<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Markets</title>
	<atom:link href="http://pharmaexecnews.com/category/biotechnology/markets-biotechnology/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Fast Company Highlights 10 Top Innovators in Biotech</title>
		<link>http://pharmaexecnews.com/biotechnology/fast-company-highlights-10-top-innovators-biotech/</link>
		<comments>http://pharmaexecnews.com/biotechnology/fast-company-highlights-10-top-innovators-biotech/#comments</comments>
		<pubDate>Fri, 04 Mar 2011 08:00:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11214</guid>
		<description><![CDATA[Fast Company has surveyed the biotech world and come up with its list of the Top 10 companies in the industry. Amyris makes the list for its work combating the malaria parasite, while Galapagos and Fate Therapeutics get nods for pipeline innovation.

Most of the companies in the magazine&#8217;s Top 10 are relatively small, but biotech [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/fast-company-highlights-10-top-innovators-biotech/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Printers Used to Produce Human Skin?</title>
		<link>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/</link>
		<comments>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/#comments</comments>
		<pubDate>Thu, 03 Mar 2011 08:00:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[dna]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11211</guid>
		<description><![CDATA[U.S. medical researchers are using modified printers to produce skin for burn victims, the project&#8217;s leader says. &#8220;We started out by taking a typical desktop inkjet cartridge. Instead of ink we use cells, which are placed in the cartridge,&#8221; Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine in Winston-Salem, N.C., told [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Naturally Occurring Brain Signaling Chemical May Be Useful in Understanding Parkinson&#8217;s</title>
		<link>http://pharmaexecnews.com/biotechnology/naturally-occurring-brain-signaling-chemical-understanding-parkinsons/</link>
		<comments>http://pharmaexecnews.com/biotechnology/naturally-occurring-brain-signaling-chemical-understanding-parkinsons/#comments</comments>
		<pubDate>Thu, 24 Feb 2011 08:00:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11193</guid>
		<description><![CDATA[Targeting the neuroinflammatory causes of Parkinson&#8217;s disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans&#8217; Administration [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/naturally-occurring-brain-signaling-chemical-understanding-parkinsons/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Small Details between &#8216;In Vivo&#8217; and &#8216;In Vitro&#8217; Studies Make for Big Differences</title>
		<link>http://pharmaexecnews.com/biotechnology/small-details-in-vivo-in-vitro-studies-big-differences/</link>
		<comments>http://pharmaexecnews.com/biotechnology/small-details-in-vivo-in-vitro-studies-big-differences/#comments</comments>
		<pubDate>Tue, 22 Feb 2011 08:00:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11185</guid>
		<description><![CDATA[Exocytosis, the fundamental process by which cells secrete hormones such as insulin and other useful biological substances, is regulated far differently in life than in laboratory tissue cultures and explanted organs, according to research presented at the American Society of Cell Biology&#8217;s 50th Annual Meeting in Philadelphia.  The unexpected findings that exocytosis regulation &#8220;in vivo&#8221; [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/small-details-in-vivo-in-vitro-studies-big-differences/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mental Retardation Gene Provides Insights into Brain Formation</title>
		<link>http://pharmaexecnews.com/biotechnology/mental-retardation-gene-insights-brain-formation/</link>
		<comments>http://pharmaexecnews.com/biotechnology/mental-retardation-gene-insights-brain-formation/#comments</comments>
		<pubDate>Mon, 21 Feb 2011 08:00:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11182</guid>
		<description><![CDATA[Scientists at Duke University Medical  Center have uncovered clues to memory and learning by exploring the function of a single gene that governs how neurons form new connections. The finding may also provide insights into a form of human mental retardation. In a study published in the Journal of Neuroscience, the scientists explored the [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/mental-retardation-gene-insights-brain-formation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CRO&#8217;s iPhone App Gives On-demand Study Updates</title>
		<link>http://pharmaexecnews.com/biotechnology/cros-iphone-app-ondemand-study-updates/</link>
		<comments>http://pharmaexecnews.com/biotechnology/cros-iphone-app-ondemand-study-updates/#comments</comments>
		<pubDate>Thu, 10 Feb 2011 08:00:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11150</guid>
		<description><![CDATA[Calvert Labs is offering clients the same kind of 24/7 on-demand smartphone access to study information that&#8217;s available to the rest of the world for news and sports. It&#8217;s linked a project-tracking iPhone application with a near-real-time and on-demand filtered information source for preclinical researchers.

The app gives users access to study schedules and progress with [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/cros-iphone-app-ondemand-study-updates/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Plan of Attack Against Breast Cancer Stem Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/#comments</comments>
		<pubDate>Fri, 21 Jan 2011 08:00:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11094</guid>
		<description><![CDATA[It was Max Wicha of the University of Michigan who first identified breast cancer stem cells back in 2003. Now, Wicha and colleagues have identified a possible way to attack these cells, which are responsible for a tumor&#8217;s growth and spread.

The researchers found that breast cancer stem cells are regulated by a type of cell [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Alfred Mann Doubles Down on Biotech</title>
		<link>http://pharmaexecnews.com/biotechnology/alfred-mann-doubles-biotech/</link>
		<comments>http://pharmaexecnews.com/biotechnology/alfred-mann-doubles-biotech/#comments</comments>
		<pubDate>Thu, 13 Jan 2011 08:00:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11068</guid>
		<description><![CDATA[As investors lay down their final bets on the FDA&#8217;s looming decision on MannKind&#8217;s Afrezza, the company&#8217;s wealthy CEO has opted to put his money where his mouth has been&#8211;doubling down on an ambitious wager that the much-maligned inhaled insulin treatment Afrezza will get a green light from regulators.

The Wall Street Journal reports that Alfred [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/alfred-mann-doubles-biotech/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Burrill Predicts Big Surge in Biotech Buyouts for 2011</title>
		<link>http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/</link>
		<comments>http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/#comments</comments>
		<pubDate>Mon, 10 Jan 2011 08:00:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Deals and Mergers]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11057</guid>
		<description><![CDATA[Big upfront fees are out. Milestones are in. Partnerships will stay hot. The IPO window will stay open, despite a lackluster record in 2010. And investor confidence will grow, helping public biotech companies outperform the general market.

Those are some of the broad-stroke predictions being made by the self-styled biotech &#8216;guru&#8217; Steven Burrill, who regularly commands [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/burrill-predicts-big-surge-biotech-buyouts-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Human Fetal Immune System Arises from Entirely Different Source than Adult Immune System</title>
		<link>http://pharmaexecnews.com/biotechnology/human-fetal-immune-system-arises-source-adult-immune-system/</link>
		<comments>http://pharmaexecnews.com/biotechnology/human-fetal-immune-system-arises-source-adult-immune-system/#comments</comments>
		<pubDate>Mon, 03 Jan 2011 08:00:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene therapy]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11032</guid>
		<description><![CDATA[UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.  The finding could lead to a better understanding of how newborns respond to both infections and vaccines, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/human-fetal-immune-system-arises-source-adult-immune-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

